- Home
- GIGM vs VVOS Comparison
GIGM vs VVOS Comparison
Compare GIGM & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIGM | VVOS |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 19.4M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GIGM | VVOS |
|---|---|---|
| Price | $1.46 | $2.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 4.0K | ★ 133.2K |
| Earning Date | 10-30-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,397,000.00 | ★ $17,317,000.00 |
| Revenue This Year | N/A | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 10.11 | ★ 18.76 |
| 52 Week Low | $1.38 | $1.93 |
| 52 Week High | $1.89 | $7.95 |
Technical Indicators
Market Signals| Indicator | GIGM | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 41.04 |
| Support Level | $1.50 | $1.93 |
| Resistance Level | $1.56 | $2.28 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 13.33 | 35.21 |
Price Performance
Historical ComparisonAbout GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.